Client Situation
Our client is a leading provider of pharmaceutical products for ultra-rare disorders. Their objective was to understand the treatment landscape, competitive pharmacotherapies in use, public and third-party funding opportunities, and pricing rules for ultra-rare neuromuscular disorders for the markets in scope